These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 8687152

  • 1. Palliative chemotherapy in metastatic colorectal carcinoma: comparison of two chemotherapeutic regimens.
    Bremnes RM, Wist EA.
    Anticancer Res; 1996; 16(2):921-6. PubMed ID: 8687152
    [Abstract] [Full Text] [Related]

  • 2. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U, Wilke H, Seeber S.
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [Abstract] [Full Text] [Related]

  • 3. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V, Majello E, Testa A, Pezzella G, Giuseppe S, Giotta F, Riccardi F, Fortunato S, Colucci G, Gebbia N.
    Cancer; 1996 Sep 15; 78(6):1300-7. PubMed ID: 8826954
    [Abstract] [Full Text] [Related]

  • 4. [A new sequential chemotherapy of methotrexate with 5-fluorouracil against advanced colo-rectal cancer].
    Fujiki T, Futatsuki K, Akazawa S, Yamamoto K, Miyazaki M, Kanda Y, Amemiya K, Uchida N, Oishi T.
    Gan To Kagaku Ryoho; 1993 Apr 15; 20(5):603-9. PubMed ID: 8470917
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer.
    Sobrero AF, Aschele C, Guglielmi AP, Mori AM, Tixi LM, Bolli EA, Rosso R, Mammoliti S, Rollandi GA, Bertoglio S.
    Clin Cancer Res; 1995 Sep 15; 1(9):955-60. PubMed ID: 9816066
    [Abstract] [Full Text] [Related]

  • 7. Postsurgical sequential methotrexate/5-FU and leucovorin on outpatient basis for advanced colorectal carcinoma.
    Tokunaga Y, Kitaoka A, Yagi T, Tokuka A, Ohsumi K.
    Hepatogastroenterology; 2001 Sep 15; 48(37):128-32. PubMed ID: 11268947
    [Abstract] [Full Text] [Related]

  • 8. Palliative second-line treatment with weekly high-dose 5-fluorouracil as 24-hour infusion and folinic acid (AIO) plus oxaliplatin after pre-treatment with the AIO-regimen in colorectal cancer (CRC).
    Link K, Happich K, Schirner I, Jüngert B, Brückl V, Männlein G, Brückl WM, Merkel S, Göhl J, Hohenberger W, Hahn EG, Wein A.
    Anticancer Res; 2004 Sep 15; 24(1):385-91. PubMed ID: 15015625
    [Abstract] [Full Text] [Related]

  • 9. Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma.
    Ribas A, Albanell J, Solé-Calvo LA, Gallardo E, Bellmunt J, Vera R, Vidal R, Carulla J, Baselga J.
    Cancer; 1998 Mar 01; 82(5):878-85. PubMed ID: 9486577
    [Abstract] [Full Text] [Related]

  • 10. [Sequential methotrexate-5-fluorouracil (MTX-5-FU) treatment of patients with advanced gastric and colorectal cancer. Sequential Methotrexate-5-FU Study Group].
    Murakami M, Ota K, Miyazaki T, Niitsu Y, Wakui A, Yokoyama M, Kanamaru R, Futatsuki K, Akazawa S, Sakai Y.
    Gan To Kagaku Ryoho; 1987 Aug 01; 14(8):2482-90. PubMed ID: 3619460
    [Abstract] [Full Text] [Related]

  • 11. Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.
    Yamada Y, Ohtsu A, Boku N, Miyata Y, Shimada Y, Doi T, Muro K, Muto M, Hamaguchi T, Mera K, Yano T, Tanigawara Y, Shirao K.
    Jpn J Clin Oncol; 2006 Apr 01; 36(4):218-23. PubMed ID: 16684860
    [Abstract] [Full Text] [Related]

  • 12. Phase II study of sequential methotrexate and 5-FU plus mitomycin and leucovorin in patients with disseminated large bowel cancer: a Northern California Oncology Group study.
    Ignoffo RJ, Friedman MA, Gribble M, Hannigan J, Reynolds R, Yu KP, Schiff S, Congdon JE.
    Cancer Treat Rep; 1984 Apr 01; 68(7-8):983-8. PubMed ID: 6611204
    [Abstract] [Full Text] [Related]

  • 13. 5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer.
    Sobrero A, Guglielmi A, Cirillo M, Recaldin E, Frassineti GL, Aschele C, Ravaioli A, Testore P, Caroti C, Gallo L, Pessi MA, Cortesi E, Turci D, Grossi F, Labianca R.
    Br J Cancer; 2001 Apr 20; 84(8):1023-8. PubMed ID: 11308248
    [Abstract] [Full Text] [Related]

  • 14. Double modulation with methotrexate and L-leucovorin of weekly 24- hour fluorouracil infusion in fluorouracil-refractory colorectal cancer.
    Colleoni M, Nelli P, Vicario G, Pancheri F, Sgarbossa G, Manente P.
    Anticancer Res; 1996 Apr 20; 16(5B):3101-4. PubMed ID: 8920775
    [Abstract] [Full Text] [Related]

  • 15. Double modulation of 5-fluorouracil by leucovorin and low-dose methotrexate in advanced colorectal cancer.
    Stabuc B, Markovic A, Plesnicar A, Cizej TE.
    Neoplasma; 2000 Apr 20; 47(4):248-52. PubMed ID: 11043831
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
    Yoshino T, Boku N, Onozawa Y, Hironaka S, Fukutomi A, Yamaguchi Y, Hasuike N, Yamazaki K, Machida N, Ono H.
    Jpn J Clin Oncol; 2007 Sep 20; 37(9):686-91. PubMed ID: 17720736
    [Abstract] [Full Text] [Related]

  • 17. [An institution-randomized trial of 5-fluorouracil and l-leucovorin therapy given monthly versus every two months to patients with advanced colorectal carcinoma].
    Hasegawa S, Akaike M, Yamamoto Y, Shiraishi R, Ozawa Y, Suzuki H, Miyazaki T, Kasahara A, Makino T, Tamura I, Tanabe H, Rino Y.
    Gan To Kagaku Ryoho; 2004 May 20; 31(5):729-33. PubMed ID: 15170981
    [Abstract] [Full Text] [Related]

  • 18. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH, Cheng AL, Hsu C, Yang CH, Lu YS, Lin CC, Bu CF, Yeh KH.
    Anticancer Res; 2002 May 20; 22(6B):3621-7. PubMed ID: 12552966
    [Abstract] [Full Text] [Related]

  • 19. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I, Jelić S, Radosavljević D, Nikolić-Tomasević A.
    Srp Arh Celok Lek; 1998 May 20; 126(9-10):355-61. PubMed ID: 9863407
    [Abstract] [Full Text] [Related]

  • 20. Oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX-4) as salvage chemotherapy in patients with pretreated colorectal cancer.
    Shitara K, Munakata M, Muto O, Kasai M, Okada R, Mitobe S, Sakata Y.
    Gan To Kagaku Ryoho; 2007 Jul 20; 34(7):1079-84. PubMed ID: 17637544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.